In Focus: data completeness

Real-world data (RWD) is a valuable addition to the scientific knowledge gained from clinical trials, but to be most useful to researchers, RWD must achieve a level of completeness that ...

Read more

Virtual ISPOR 2021 – event coverage

The Evidence Base® is proud to partner with the International Society for Pharmacoeconomics and Outcomes Research (ISPOR; NJ, USA) to bring you news, coverage, expert insights and ...

Read more

World Cancer Day 2021

World Cancer Day, an initiative of the Union of International Cancer Control (Geneva, Switzerland), is marked each year on 4 February and aims to raise awareness and improve education ...

Read more

In Focus: patient-relevant outcomes and engagement

In this latest editorial ‘In Focus’ feature, we bring you exclusive content surrounding the current and future states of patient-relevant outcomes and engagement in ...

Read more

In Focus: the viability of real-world data and evidence

In this latest editorial feature, we bring you exclusive editorial content from industry experts exploring the feasibility, credibility and validity of real-world data studies. We hope ...

Read more

In Focus: real-world evidence in regulatory decision-making

In this latest editorial ‘In Focus’ feature, we bring you exclusive content surrounding the current and future states of utilizing real-world evidence in regulatory decision ...

Read more

World Cancer Day 2020

For World Cancer Day (4 February 2020), we have highlighted a selection of our top real-world evidence articles pertaining to oncology research and therapeutic development, which we ...

Read more

In Focus: transparency in real-world evidence

Transparency – from methods of data generation to analytic models employed – is an essential aspect of real-world evidence generation and research. Collaboratively working toward ...

Read more

In Focus: treatment sequencing in oncology management

In this editorial feature, The Evidence Base, Oncology Central and the journal Future Oncology have come together to explore recent developments and challenges in treatment sequencing ...

Read more